quinazolines has been researched along with Ascites in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (58.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (8.33) | 29.6817 |
2010's | 4 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boers-Sonderen, MJ; Mulder, SF; Punt, CJ; van der Heijden, HF; van Herpen, CM; Vissers, KC | 1 |
Bertrand, M; Correa, RJ; DiMattia, GE; Fazio, EN; McGee, J; Peart, TM; Préfontaine, M; Shepherd, TG; Sugimoto, A; Valdes, YR | 1 |
Ellard, SL; Fisher, B; Grimshaw, R; Hirte, H; Oza, A; Seymour, L; Swenerton, K; Tsao, M | 1 |
Ishida, T; Katsuura, Y; Minemura, H; Misa, K; Munakata, M; Tachihara, M; Uematsu, M | 1 |
Hanajiri, K; Maruyama, T; Mitsui, H; Nakajima, J; Omata, M | 1 |
AMAYA, C; GORDILLO, R; PAZ CARRANZA, J | 1 |
GRIFFIN, R; STEIGMANN, F | 1 |
BRENES, C; FARRERASVALENTI, P; ROZMAN, C | 1 |
GELFAND, M; WESSELS, P | 1 |
Amand, RS; Chen, KK; Modest, EJ; Rosowsky, A | 1 |
Lowenthal, DT; Shear, L | 1 |
Hillenbrand, P; Sherlock, S | 1 |
2 trial(s) available for quinazolines and Ascites
Article | Year |
---|---|
A phase II study of cediranib as palliative treatment in patients with symptomatic malignant ascites or pleural effusion.
Topics: Administration, Oral; Aged; Antineoplastic Agents; Ascites; Disease Progression; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Palliative Care; Paracentesis; Pleural Effusion; Protein Kinase Inhibitors; Quality of Life; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Time Factors; Treatment Outcome; Vascular Endothelial Growth Factor Receptor-1 | 2014 |
A phase II study of erlotinib (OSI-774) given in combination with carboplatin in patients with recurrent epithelial ovarian cancer (NCIC CTG IND.149).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; CA-125 Antigen; Carboplatin; Disease-Free Survival; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Quinazolines | 2010 |
10 other study(ies) available for quinazolines and Ascites
Article | Year |
---|---|
Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability.
Topics: Allosteric Regulation; Antineoplastic Agents; Ascites; Autophagy; Benzylamines; Cell Line, Tumor; Cell Survival; Chloroquine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Inhibitory Concentration 50; Ovarian Neoplasms; Proto-Oncogene Proteins c-akt; Quinazolines; Quinoxalines; Spheroids, Cellular | 2014 |
Increase of ascites and pleural effusion misleading assessment of antitumor response to erlotinib in adenocarcinoma of the lung.
Topics: Adenocarcinoma; Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Ascites; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Pleural Effusion, Malignant; Prednisolone; Quinazolines | 2011 |
Clinical efficacy and toxiciy of gefitinib in patients with lung cancer.
Topics: Aged; Antineoplastic Agents; Ascites; Carcinoma, Non-Small-Cell Lung; Gefitinib; Hepatitis C, Chronic; Humans; Hypoalbuminemia; Liver Cirrhosis; Lung Diseases, Interstitial; Lung Neoplasms; Male; Quinazolines | 2003 |
[Therapeutic studies with quinethazone, a new saluretic. II. Quinethazone and ascites].
Topics: Ascites; Diuretics; Quinazolines; Sulfonamides | 1962 |
EVALUATION OF QUINETHAZONE, A NEW DIURETIC.
Topics: Ascites; Coronary Disease; Diuretics; Edema; Hypertension; Liver Cirrhosis; Quinazolines; Rheumatic Heart Disease; Sulfonamides | 1963 |
[CLINICAL STUDY OF A DIURETIC, QUINETHAZONE].
Topics: Anuria; Ascites; Blood Chemical Analysis; Diuretics; Edema; Liver Cirrhosis; Pharmacology; Quinazolines; Statistics as Topic; Sulfonamides; Toxicology | 1963 |
ACANTHOCHEILONEMA PERSTANS IN A EUROPEAN FEMALE. A DISCUSSION OF ITS POSSIBLE PATHOGENICITY AND A SUGGESTED NEW SYNDROME.
Topics: Acanthocheilonema; Animals; Ascites; Betamethasone; Biopsy; Diethylcarbamazine; Dipetalonema; Drug Therapy; Female; Filariasis; Heart Diseases; Humans; Liver Diseases; Mansonella; Quinazolines; Sulfonamides; Toxicology; Virulence; White People; Zimbabwe | 1964 |
Chemical and biological studies on 1,2-dihydro-s-triazines. 18. Synthesis of 1-(5,6- and 5,7-dichloro-2-naphthyl) derivatives and related compounds as candidate antimalarial and antitumor agents.
Topics: Animals; Antimalarials; Antineoplastic Agents; Ascites; Biguanides; Carcinoma, Squamous Cell; Cells; Chlorine; Humans; Leukemia, Experimental; Mice; Mice, Inbred DBA; Naphthalenes; Neoplasm Transplantation; Plasmodium; Plasmodium berghei; Quinazolines; Streptococcus; Transplantation, Homologous; Triazines | 1973 |
Use of a new diuretic agent (metolazone) in patients with edema and ascites.
Topics: Ascites; Blood Urea Nitrogen; Creatinine; Diuretics; Edema; Furosemide; Humans; Injections, Intravenous; Kidney Diseases; Liver Cirrhosis; Natriuresis; Potassium; Protein Binding; Quinazolines; Sodium; Sulfonamides; Time Factors; Urea | 1973 |
Use of metolazone in the treatment of ascites due to liver disease.
Topics: Adult; Ascites; Chlorides; Chronic Disease; Diuretics; Female; Hepatic Encephalopathy; Humans; Hypokalemia; Hyponatremia; Ketones; Liver Diseases; Male; Middle Aged; Nitrogen; Pyrazines; Quinazolines; Spironolactone; Sulfonamides; Uremia | 1971 |